| - GRCh37:
- Chr17:54671645-54671646
- GRCh38:
- Chr17:56594284-56594285
| NOG | A22fs | Symphalangism-brachydactyly syndrome | Pathogenic (Dec 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:54672195
- GRCh38:
- Chr17:56594834
| NOG | R204Q | not provided, Tarsal-carpal coalition syndrome | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:34025738
- GRCh38:
- Chr20:35437958
| GDF5, LOC109461476 | | Symphalangism-brachydactyly syndrome, Acromesomelic dysplasia 2B, Brachydactyly, Acromesomelic dysplasia, Chondrodysplasia | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22278070
- GRCh38:
- Chr13:21703931
| FGF9 | | Symphalangism-brachydactyly syndrome | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22278024-22278025
- GRCh38:
- Chr13:21703885-21703886
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22277775
- GRCh38:
- Chr13:21703636
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22277081
- GRCh38:
- Chr13:21702942
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22276053-22276056
- GRCh38:
- Chr13:21701914-21701917
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22276009
- GRCh38:
- Chr13:21701870
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275849-22275850
- GRCh38:
- Chr13:21701710-21701711
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275848-22275849
- GRCh38:
- Chr13:21701709-21701710
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275848-22275849
- GRCh38:
- Chr13:21701709-21701710
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275847-22275848
- GRCh38:
- Chr13:21701708-21701709
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275845-22275848
- GRCh38:
- Chr13:21701706-21701709
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275843-22275848
- GRCh38:
- Chr13:21701704-21701709
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22275839-22275840
- GRCh38:
- Chr13:21701700-21701701
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22246014-22246015
- GRCh38:
- Chr13:21671875-21671876
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22245935-22245936
- GRCh38:
- Chr13:21671796-21671797
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22245934-22245935
- GRCh38:
- Chr13:21671795-21671796
| FGF9 | | Symphalangism-brachydactyly syndrome | Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22245927-22245928
- GRCh38:
- Chr13:21671788-21671789
| FGF9 | | Symphalangism-brachydactyly syndrome | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22245927-22245928
- GRCh38:
- Chr13:21671788-21671789
| FGF9 | | Symphalangism-brachydactyly syndrome | Benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22245710
- GRCh38:
- Chr13:21671571
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr13:22245461-22245462
- GRCh38:
- Chr13:21671322-21671323
| FGF9 | | Symphalangism-brachydactyly syndrome | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:54672280
- GRCh38:
- Chr17:56594919
| NOG | C232W | Symphalangism-brachydactyly syndrome | Pathogenic (Jun 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr17:54672199
- GRCh38:
- Chr17:56594838
| NOG | W205C | Symphalangism-brachydactyly syndrome | Pathogenic (Apr 1, 2005) | no assertion criteria provided |
| - GRCh37:
- Chr17:54672198
- GRCh38:
- Chr17:56594837
| NOG | W205* | Symphalangism-brachydactyly syndrome | Pathogenic (Apr 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr17:54671642
- GRCh38:
- Chr17:56594281
| NOG | L20fs | Symphalangism-brachydactyly syndrome | Pathogenic (Dec 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr17:54672233
- GRCh38:
- Chr17:56594872
| NOG | W217G | Symphalangism-brachydactyly syndrome | Pathogenic (Mar 1, 1999) | no assertion criteria provided |